Besides this, strategies to inhibit the insulin-degrading enzyme (IDE) have also been proven to be beneficial in the case of T2DM and Alzheimer’s disease (A.D) and alterations of the levels of insulin in the cytosol [39]. This evidence concerns the gene IDE and type 2 diabetes mellitus.